Market Research Report
Vascular Access Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
|Vascular Access Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)|
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 111 Pages
Delivery time: 2-3 business days
The global vascular access devices market is expected to register a CAGR of nearly 6.5% during the forecast period. Over the past decade, there has been a rise in the prevalence of several chronic diseases that need vascular access treatment. Some of the major chronic diseases include cancer, kidney failure, and heart diseases, among others. Along with these, there are several lifestyle disorders relating to chronic and non-communicable disease conditions, such as hypertension, diabetes, obesity, and depression, among others, which need critical care during their hospitalization.
The prevalence of end-stage renal disease (ESRD), worldwide, is further increasing at a significant rate, resulting in chronic kidney disease (CKD). In 2017, in the United States, around 30 million people (15% of US adults) were found suffering from chronic kidney disease (CKD). CKD was found to be more common in women (16%) than in men (13%). For patients undergoing dialysis treatment, the ideal method of vascular access is through an arteriovenous fistula (ANF), by referring to a nephrologist about replacement therapy. The vascular access catheter devices are also significantly used in the case of chemotherapies.
According to the Center for Disease Control and Prevention (CDC), in the United States, nearly 0.65 million cancer patients receive chemotherapy in an outpatient oncology clinic annually. With the rising prevalence of chronic diseases and lifestyle disorders, the vascular access procedures are increasingly being used for intravenous antibiotic treatment, long intravenous nutritional support, and drawing of blood samples. Hence this is expected to draw the attention of several multinational medical devices companies to invest and launch new products, thus, acting as one of the major drivers for this market.
The drug administration segment is estimated to account for the largest share of the market as the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases. Catheters are used for a variety of functions, including administering drugs, drawing blood, and specialized treatments like hemodialysis. Vascular access catheters can be inserted either peripherally in a patient's arm or centrally, such as in the patient's jugular.
North America segment is expected to account for the largest share of the market that can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices.
Additionally, in a large number of cases of all the end-stage renal disease (ESRD), dialysis patients are treated via a catheter, which is performed in an outpatient setting, thus, reducing the hospitalization of ESRD patients by allowing the non-emergency interventional procedures to be carried out. The factors, such as government guidelines for the regulation of medical devices by the company, and better healthcare infrastructure, etc., play a key role in increasing the business and in the launching of new products by multinational companies, and thereby, contributing the market growth.
The vascular access devices market is highly competitive and there are several small to mid-sized companies that are posing strong competition to gain the market share. However, few companies that are doing a good business in the market include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation, and Fresenius Medical Care.